Mantle cell lymphoma: optimizing responses in treatment-naïve and difficult-to-treat patients
Mantle cell lymphoma: optimizing responses in treatmen
Advancing care in Waldenström macroglobulinemia: Clinical and real-world perspectives
Advancing care in Waldenström macroglobulinemia: Clini
Follicular lymphoma: Efficacy and safety updates
Follicular lymphoma: Efficacy and safety updates In
Pushing the boundaries further in the management of CLL
Pushing the boundaries further in the management of CL
Editorial – ASH 2024
Editorial – ASH 2024 Portrait © Uni Klinik U
Innovative agents in marginal zone lymphoma and other B-cell malignancies
Innovative agents in marginal zone lymphoma and
Exploring chemotherapy-free approaches in the treatment of DLBCL
Exploring chemotherapy-free approaches in the tr
Updated findings in CLL with a focus on BTK- and Bcl-2–targeted therapies
Updated findings in CLL with a focus on BTK- and
Follicular lymphoma: BTK inhibition and bispecific antibodies
Follicular lymphoma: BTK inhibition and bispecif
Improving responses in multiple myeloma
Improving responses in multiple myeloma PERS
